Abstract
Purpose
To investigate the clinical features, diagnosis, treatment and prognosis of otolaryngological extranodal RDD.
Methods
A retrospective analysis was performed on 16 patients who were initially diagnosed and treated with otolaryngological extranodal RDD in our hospital from January 2013 to January 2019.
Results
There were 9 females and 7 males. The mean diagnostic age was 45.35. Nasal, laryngeal and otic RDD were, respectively, accounting for 56.25%, 31.25% and 12.5%. The median interval diagnostic time was individually 1, 0.5 and 0.2 year for nasal, laryngeal and otic RDD. The most common symptoms were separately progressive nasal congestion, dyspnea, otorrhea in nasal, laryngeal and otic RDD. 13 had cervical lymph node swelling on MRI. Surgery or postoperative radiotherapy were conformed. In the end, 14 patients with RDD survived. The survival rate is as high as 87.5%. One of them died of RDD in the fifth year. One case was lost to follow-up 2 years after treatment. Patients survive for at least 2 years and up to 9 years. There was no significant difference in life expectancy of extranodal RDD among different parts of ENT (P = 0.508 > 0.05). The average ages of laryngeal and nasal RDD were similar (P = 0.898 > 0.05). However, the age of both was significantly higher than ear RDD (P = 0.023 and 0.019 < 0.05).
Conclusions
The average diagnostic age was more than 20 years. Nasal RDD was the most common in this area. All laryngeal RDD had infiltrated subglottis. Functional surgery and postoperative radiotherapy can be used to achieve long-term remission and survival.
Similar content being viewed by others
References
Yajima M, Nakajima K, Hirato J, Chikamatsu K (2016) Extranodal soft tissue Rosai–Dorfman disease of the head and neck and its diagnostic difficulty. Auris Nasus Larynx 43(3):345–349
Destombes P (1965) Adenitis with lipid excess, in children or young adults, seen in the Antilles and in Mali (4 cases). Bull Soc Pathol Exot Filiales 58:1169–1175
Rosai J, Dorfman RF (1969) Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol 87(1):63–70
Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J (2016) Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127:2672–2681
Delacretaz F, Meugé-Moraw C, Anwar D, Borisch B, Chave JP (1991) Sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman disease) in an HIV-positive patient. Virchows Arch A Pathol Anat Histopathol 419(3):251–254
Brand CB, Schneider JW, Schubert P (2020) Rosai–Dorfman disease: an overview. J Clin Pathol 73(11):697–705
Garces S, Medeiros LJ, Patel KP (2017) Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai–Dorfman disease. Mod Pathol 30(2):1367–2137
Nasany RA, Reiner AS, Francis JH, Abla O, Panageas KS, Diamond EL (2022) Rosai–Dorfman–Destombes disease of the nervous system: a systematic literature review. Orphanet J Rare Dis 17(1):92
Mahzoni P, Hani M, Bagheri M, Moqtader B, Zavareh MH (2002) Cutaneous Rosai–Dorfman disease is a distinct clinical entity. Am J Dermatopathol 24:385–391
Brenn T, Calonje E, Granter SR (2002) Cutaneous Rosai–Dorfman disease is a distinct clinical entity. Am J Dermatopathol 24:385–391
Chang LY, Kou T, Chan HL (2002) Extranodal Rosai–Dorfman disease with cutaneous. Ophthalmic and laryngeal involvement: report of a case treated with isotretinoin. Int J Dermatol 41:888–891
Ma YL, Liang ZP, Xu SE, Yang ZH, Peng Y, Sun XQ, Qin G (2015) Rosai–Dorfman disease (RDD) in the paraglottic space: report of a case and review of literature. Int J Clin Exp Pathol 8(10):13532–13538
Niu YY, Li YJ, Wang J, Jin XF, Yang DY, Huo H, Li WY (2015) Rosai–Dorfman disease (RDD) in the paraglottic space: report of a case and review of literature. Int J Clin Exp Pathol 8(10):13532–13538
Emile JF, Abla O, Fraitag S (2016) Revised classification of histiocytoses and neoplasms of the macrophagedendritic cell lineages. Blood 127(22):2672–2681
Pulsoni A, Anghel G, Falcucci P (2002) Treatment of sinus histocytosis with massive lymphadenopathy (Rosai Dorfman disease): report of a case and literature review. Am J Hematol 69(1):67–71
Wei C, Zhou DB (2021) Long-time remission of laryngeal Rosai–Dorfman disease with thalidomide: a report of three cases. Hematology 26(1):552–555
Goyal G, Ravindran A, Young JR, Shah MV, Bennani NN, Patnaik MM, Nowakowski GS, Thanarajasingam G, Habermann TM, Vassallo R, Sher T, Parikh SA, Rech KL, Go RS (2020) Clinicopathological features, treatment approaches, and outcomes in Rosai–Dorfman disease. Haematologica 105(2):348–357
La Barge III DV, Salzman KL, Harnsberger HR, Ginsberg LE, Hamilton BE, Wiggins III RH, Hudgins PA (2008) Sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease): imaging manifestations in otolaryngology. AJR Am J Roentgenol 191(6):W299-306
Funding
This research is supported by the Science and Technology Commission of Shanghai Municipality of China (Grant nos. 20Y11901900, 21Y11912000), the Health and Family Planning Commission of Shanghai Municipality of China (Grant no. 2019SY059), the Shanghai Health Bureau (Grant no. 20214Y0082) and the Double First-class Scientific Research Projects of Fudan University (Grant no. IDF158017/028).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, C., Chen, J., He, P. et al. Clinical features, diagnosis, treatment and prognosis of otolaryngological extranodal sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease, RDD). Eur Arch Otorhinolaryngol 280, 861–867 (2023). https://doi.org/10.1007/s00405-022-07646-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-022-07646-7